PRODUCTS

Easy and fast set up mobile testing laboratory unit for COVID-19 testing adaptable for other diseases and pathogens.

The rTEST COVID-19 qPCR Rapid kit is a qualitative in vitro diagnostic test designed to detect the presence of SARS-CoV-2 genetic material in biological samples obtained by gargling without RNA extraction. 

The rTEST COVID-19 qPCR Allplex kit is an innovative, improved, and re-designed version of the WHO- recommended Charite, Berlin protocol. 

rTEST COVID-19 qPCR Multivariant kit is a qualitative in vitro confirmatory test designed to detect the presence of multiple SARS-CoV-2 variants

The Vivid COVID-19 LAMP Direct-G diagnostic kit is designed to detect SARS-CoV-2 viral RNA in gargle samples without an RNA extraction step.

The rTEST COVID-19 B.1.1.7 qPCR kit is a qualitative in vitro confirmatory test designed for specific detection of the B.1.1.7 variant of SARS-CoV-2 first described by the United Kingdom.

The rTEST COVID-19 qPCR Allplex kit is an innovative, improved, and re-designed version of the WHO- recommended Charite, Berlin protocol. 

Our kit is an innovative, improved, and re-designed version of the WHO-recommended Charité, Berlin protocol, along with a newly designed differential test distinguishing between SARS-CoV-2, IAV and IBV.

rTEST COVID-19 qPCR kit enables multiplexed detection of SARS-CoV-2 (confirmation of positive COVID-19) and human RNA.

MultiplexDX offers a wide range of bioinformatics services, including genome assembly, gene expression, metagenomics analyses, and data visualization.

A single kit is sufficient for 400 testing reactions and also offers flexibility in testing by permitting either single gene screening or precision dual gene diagnostics.

The diagnostic kit vDetect COVID-19 RT-qPCR is based on an improved and re-designed Charité Berlin protocol also recommended by the WHO. The RT and qPCR are carried out in a one tube, 1-step fashion. The kit contains 3 primers/TaqMan probe mixes.

Specific Research Use Only (RUO) primers and probes for detection of severe acute respiratory syndrome coronavirus 2 - SARS-CoV-2 (previously known as “2019 novel coronavirus”) causing coronavirus disease (COVID-19).

MultiplexDX is your partner of choice for the synthesis of aptamers, siRNA, miRNA, antagomirs, qPCR probes, oligonucleotide triphosphates etc.

Companion Diagnostics. Innovative solutions for biopharma companies. 100% precise cancer profiling and 100% accurate companion biomarker quantification. MultiplexDX innovative technologies for cancer diagnostics market.

100% precise and 100% accurate cancer diagnostic test based on MultiplexDX IP-based technologies, which combine visualization and sequencing methods to quantify 7 or more cancer markers and give each diagnosis a specific “barcode”. This biotech innovation is revolutionary for cancer diagnostic market.

Barcoded pre-adenylated adapters, 3'-adapters with the simplest small RNA sequencing protocol, Illumina sequencing compatible, errors reduction due to gel purification. Small rna sequencing library preparation for illumina platforms. Buy sequencing adapters.

The simplest, gel-free and economical small RNA sequencing protocol using barcoded pre-adenylated 3’-adapters. Innovative MultiplexDX solutions for cancer diagnostic market. Illumina sequencing compatible. Small rna sequencing library preparation for illumina platforms. Order small RNA sequencing adapters.

Multi-labeled FISH probes, allowing room temperature fish and room temperature hybridization. The simplest RNA fluorescent in situ hybridization protocol. Innovative MultiplexDX technologies for cancer diagnostic market.